{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:40Z","timestamp":1783555240681,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the safety and efficacy of phacoemulsification combined with Micropulse transscleral cyclophotocoagulation (MP-TSCPC) in glaucoma patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective case-note review. The participants were adult patients with diagnoses of glaucoma and cataract who required a further reduction in IOP or a reduction in the number of glaucoma drops. All consecutive patients who underwent cataract surgery (CS) combined with MP-TSCPC laser between October 2018 and July 2019 were included in the study. The effect on visual acuity (VA), intraocular pressure (IOP) and number of anti-glaucoma drops were evaluated at 6 and 12 months in addition to any complications that occurred during any time point of the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>42 eyes were included in the study. Mean IOP was reduced from 19.5\u2009\u00b1\u20095.4\u2009mmHg by 22.5% to 15.1\u2009\u00b1\u20094.6 at 6 months post-operatively and by 19.5% to 15\u2009\u00b1\u20096.6\u2009mm Hg at 12 months (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 at both time points). The number of anti-glaucoma medications also reduced significantly from 2.8\u2009\u00b1\u20091.3 to 1.6\u2009\u00b1\u20091.2 at 6 months and to 2.2\u2009\u00b1\u20091.3 at 12 months (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 at both time points). The success rate was 56% at 6 months and 54% at 12 months. 54.7% of our patients who completed 12 months follow up had an improvement or unchanged vision at the last visits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first study evaluating the effect of cataract surgery combined with MP-TSCPC in glaucoma patients. We demonstrated that this led to a reduction in IOP and the number of anti-glaucoma medications at 6 and 12-month postoperatively. The majority of patients had either stable or better vision at 12 months follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-021-01826-1","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T05:02:38Z","timestamp":1636174958000},"page":"2188-2191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Phacoemulsification combined with micropulse cyclodiode laser in glaucoma patients: efficacy and safety"],"prefix":"10.1038","volume":"36","author":[{"given":"Arij","family":"Daas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-1656","authenticated-orcid":false,"given":"Thomas","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Danieliute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-9703","authenticated-orcid":false,"given":"Saurabh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Amon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3897-1633","authenticated-orcid":false,"given":"Kin Sheng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"1826_CR1","first-page":"415","volume":"19","author":"AG Abraham","year":"2006","unstructured":"Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmol Clin North Am. 2006;19:415\u201325.","journal-title":"Ophthalmol Clin North Am"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"262 LP","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262 LP\u2013267.","journal-title":"Br J Ophthalmol."},{"key":"1826_CR3","doi-asserted-by":"crossref","unstructured":"Alaghband P, Beltran-Agull\u00f3 L, Galvis EA, Overby DR, Lim KS. Effect of phacoemulsification on facility of outflow. Br J Ophthalmol. 2018;102:1520\u20136.","DOI":"10.1136\/bjophthalmol-2017-311548"},{"key":"1826_CR4","unstructured":"Johnstone M, American JM-27th AM of the, 2017 undefined. Transcleral Laser Induces Aqueous Outflow Pathway Motion & Reorganization. https:\/\/www.iridex.wsivirtual.com\/portals\/0\/pdf\/Transcleral-induces-aqueous-outflow-pathway-motion-and-reorganization-Dr.pdf. Accessed 11 December 2019."},{"key":"1826_CR5","doi-asserted-by":"crossref","unstructured":"Aquino MCD, Barton K, Tan AMWT, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43:40\u20136.","DOI":"10.1111\/ceo.12360"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","volume":"38","author":"AM Tan","year":"2010","unstructured":"Tan AM, Chockalingam M, Aquino MC, Lim ZIL, See JLS, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38:266\u201372.","journal-title":"Clin Exp Ophthalmol"},{"key":"1826_CR7","doi-asserted-by":"crossref","unstructured":"Emanuel ME, Grover DS, Fellman RL, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26:726\u20139.","DOI":"10.1097\/IJG.0000000000000715"},{"key":"1826_CR8","doi-asserted-by":"crossref","unstructured":"Hui LJ, Shi Y, Amoozgar B, et al. Outcome of micropulse laser transscleral cyclophotocoagulation on pediatric versus adult glaucoma patients. J Glaucoma. 2017;26:936\u20139.","DOI":"10.1097\/IJG.0000000000000757"},{"key":"1826_CR9","doi-asserted-by":"crossref","unstructured":"Samuelson TW, Chang DF, Marquis R, Flowers B, Sheng LK, Ahmed IIK, et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126:29\u201337.","DOI":"10.1016\/j.ophtha.2018.09.021"},{"key":"1826_CR10","doi-asserted-by":"crossref","unstructured":"Merkur A, Damji KF, Mintsioulis G, Hodge WG. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoliation syndrome. J Cataract Refract Surg. 2001;27:528\u201332.","DOI":"10.1016\/S0886-3350(00)00753-7"},{"key":"1826_CR11","doi-asserted-by":"crossref","unstructured":"Mathalone N, Hyams M, Neiman S, Buckman G, Hod Y, Geyer O. Long-term intraocular pressure control after clear corneal phacoemulsification in glaucoma patients. J Cataract Refract Surg. 2005;88:S21-5.","DOI":"10.1016\/j.jcrs.2004.06.046"},{"key":"1826_CR12","doi-asserted-by":"crossref","unstructured":"Per\u00e4salo R. Phaco-emulsification of cataract in eyes with glaucoma. Acta Ophthalmol Scand. 1997;75;299\u2013300.","DOI":"10.1111\/j.1600-0420.1997.tb00778.x"},{"key":"1826_CR13","doi-asserted-by":"crossref","unstructured":"Shingleton BJ, Pasternack JJ, Hung JW, O\u2019Donoghue MW. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15:494\u20138.","DOI":"10.1097\/01.ijg.0000212294.31411.92"},{"key":"1826_CR14","doi-asserted-by":"crossref","unstructured":"Mansberger SL, Gordon MO, Jampel H, et al. Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology. 2012;119:1826\u201331.","DOI":"10.1016\/j.ophtha.2012.02.050"},{"key":"1826_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","volume":"28","author":"K Zaarour","year":"2019","unstructured":"Zaarour K, Abdelmassih Y, Arej N, Cherfan G, Tomey KF, Khoueir Z. Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma. 2019;28:270\u2013275.","journal-title":"J Glaucoma"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s10103-019-02934-x","volume":"35","author":"MA Preda","year":"2020","unstructured":"Preda MA, Karancsi OL, Munteanu M, Stanca HT. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma\u201418 months follow-up. Lasers Med Sci. 2020;35:1487\u201391.","journal-title":"Lasers Med Sci"},{"key":"1826_CR17","doi-asserted-by":"crossref","unstructured":"Ching HY, Wong AC, Wong CC, Woo DC, Chan CW. Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomography. Eye. 2006;20:297\u2013303.","DOI":"10.1038\/sj.eye.6701864"},{"key":"1826_CR18","doi-asserted-by":"crossref","unstructured":"Lobo CL, Faria PM, Soares MA, Bernardes RC, Cunha-Vaz JG. Macular alterations after small-incision cataract surgery. J Cataract Refract Surg. 2004;30:752\u201360.","DOI":"10.1016\/S0886-3350(03)00582-0"},{"key":"1826_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/IJG.0000000000000934","volume":"27","author":"AL Williams","year":"2018","unstructured":"Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma. 2018;27:445\u20139.","journal-title":"J Glaucoma"},{"key":"1826_CR20","doi-asserted-by":"crossref","unstructured":"Perez CI, Han Y, Rose-Nussbaumer J, Ou Y, Hsia YC. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmol Case Rep. 2019;15:100469.","DOI":"10.1016\/j.ajoc.2019.100469"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01826-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:05:35Z","timestamp":1666166735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01826-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01826-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KSL has received research grants and lectures fees from Iridex Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}